Product Information

SELEGILINE HCL 5 MG CAPSULE is a generic product labeled by Apotex Corp., priced at $0.7307 per EA under NDC 60505005502. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Dec 4, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SELEGILINE HCL 5 MG CAPSULE

SELEGILINE HYDROCHLORIDE
$0.7307per EA

Strength

5 mg/1

Manufacturer

Apotex Corp.

NDC

60505005502

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

SELEGILINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075321

FDA Approved

12/4/1998

TE Code

AB

On Market Since

7/15/1997

Pharmacological Classes

Monoamine Oxidase Inhibitor
Monoamine Oxidase Inhibitors
Monoamine Oxidase Type B Inhibitor
Monoamine Oxidase-B Inhibitors

Price Statistics

The NADAC for SELEGILINE HCL 5 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 48.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7307 per EA
All-time high$1.5538 (Nov 16, 2016)
All-time low$0.4117 (May 22, 2024)
52-week high$0.7307
52-week low$0.6067
Median price$1.1240
Average price$1.0787
Largest weekly change+51.1% (Nov 22, 2023)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

+15.0%

1Y

+20.7%

3Y

+9.7%

5Y

-26.5%

All

-48.0%

Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 2%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SELEGILINE HCL 5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for SELEGILINE HCL 5 MG CAPSULE, manufactured by Apotex Corp., is $0.7307 per EA (NDC 60505005502), effective Aug 19, 2026.

How has the price of SELEGILINE HCL 5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for SELEGILINE HCL 5 MG CAPSULE has declined 48.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SELEGILINE HCL 5 MG CAPSULE?

Since Nov 28, 2013, the NADAC for SELEGILINE HCL 5 MG CAPSULE has ranged from a low of $0.4117 (May 22, 2024) to a high of $1.5538 (Nov 16, 2016), with a median of $1.1240 per EA.

Are there cheaper alternatives to SELEGILINE HCL 5 MG CAPSULE?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SELEGILINE HCL 5 MG CAPSULE, is $0.7191 per EA — about 2% below SELEGILINE HCL 5 MG CAPSULE.

Who manufactures SELEGILINE HCL 5 MG CAPSULE?

SELEGILINE HCL 5 MG CAPSULE (NDC 60505005502) is labeled by Apotex Corp., and CMS classifies it as a generic product.